Markus Reindl
Markus Reindl publishes mostly in Neurology, Pathology and Forensic Medicine and Immunology, on topics such as Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Autoimmune Neurological Disorders and Treatments.
- World rank
- #149,732 of 7,710,434 ranked researchers
- Rank in Austria
- #1,223 of 43,330
- Works
- 427
- Citations
- 30k
- Citations per work
- 69.2
What does Markus Reindl research?
Markus Reindl's work is mostly in Medicine (54%), Immunology and Microbiology (7%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences23254.3%
- Medicine23254.3%
- Everything else13231.0%
- Life Sciences6314.7%
- 1Neurology26% of their works
- 2Pathology and Forensic Medicine23% of their works
- 3Immunology7% of their works
- 4Rheumatology6% of their works
- 5Molecular Biology4% of their works
- 6Developmental Neuroscience4% of their works
Research topics
- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Autoimmune Neurological Disorders and Treatments
- Systemic Lupus Erythematosus Research
- Neurogenesis and neuroplasticity mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Immunotherapy and Immune Responses
- Monoclonal and Polyclonal Antibodies Research
Which keywords describe Markus Reindl's research?
The keywords of their largest research topics: Cognitive Impairment, Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Neurological Disorders, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Guillain-Barré Syndrome and Autoantibodies.
- Therapeutic Antibodies
- Immunity
- Neuroinflammation
- Neurogenesis
- Innate Immunity
- Antiphospholipid Syndrome
- Paraneoplastic Syndromes
- Autoantibodies
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Neuromyelitis Optica
- Diagnostic Criteria
- Cognitive Impairment
- Multiple Sclerosis
- Neurological Disorders
- Guillain-Barré Syndrome
- Anti-NMDA Receptor Encephalitis
- Brain Development
- Systemic Lupus Erythematosus
- Adult Stem Cells
- Microglia
- Dendritic Cells
- Fc Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Cognitive Impairment3322 topics
- Diagnostic Criteria3322 topics
- Multiple Sclerosis2611 topic
- Neuromyelitis Optica2611 topic
- Neurological Disorders2592 topics
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy1881 topic
- Guillain-Barré Syndrome1881 topic
- Autoantibodies1272 topics
- Anti-NMDA Receptor Encephalitis711 topic
- Paraneoplastic Syndromes711 topic
- Brain Development672 topics
- Antiphospholipid Syndrome561 topic
- Systemic Lupus Erythematosus561 topic
- Innate Immunity482 topics
- Adult Stem Cells411 topic
- Neurogenesis411 topic
- Microglia261 topic
- Neuroinflammation261 topic
- Dendritic Cells221 topic
- Immunity221 topic
- Fc Receptors211 topic
- Therapeutic Antibodies211 topic
Where does Markus Reindl work?
Markus Reindl's main affiliation in the publication record is Innsbruck Medical University, Austria.
How many publications and citations does Markus Reindl have?
OpenAlex counts 427 works and 29,554 citations for Markus Reindl, an h-index of 82, ranking #149,732 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Markus Reindl. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.